LOTUSEYE.NS
Lotus Eye Hospital and Institute Ltd
Price:  
70.40 
INR
Volume:  
18,002.00
India | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LOTUSEYE.NS WACC - Weighted Average Cost of Capital

The WACC of Lotus Eye Hospital and Institute Ltd (LOTUSEYE.NS) is 12.2%.

The Cost of Equity of Lotus Eye Hospital and Institute Ltd (LOTUSEYE.NS) is 12.25%.
The Cost of Debt of Lotus Eye Hospital and Institute Ltd (LOTUSEYE.NS) is 14.55%.

Range Selected
Cost of equity 10.80% - 13.70% 12.25%
Tax rate 27.30% - 27.60% 27.45%
Cost of debt 7.50% - 21.60% 14.55%
WACC 10.7% - 13.7% 12.2%
WACC

LOTUSEYE.NS WACC calculation

Category Low High
Long-term bond rate 6.9% 7.4%
Equity market risk premium 8.3% 9.3%
Adjusted beta 0.47 0.62
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.80% 13.70%
Tax rate 27.30% 27.60%
Debt/Equity ratio 0.02 0.02
Cost of debt 7.50% 21.60%
After-tax WACC 10.7% 13.7%
Selected WACC 12.2%

LOTUSEYE.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for LOTUSEYE.NS:

cost_of_equity (12.25%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.47) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.